K. Ilieva

发表

Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases

Kristina M. Ilieva, T. Spector, J. Bell, 2020, Cells.

In Planta Glycan Engineering and Functional Activities of IgE Antibodies

Kristina M. Ilieva, D. Maresch, F. Altmann, 2019, Front. Bioeng. Biotechnol..

ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure

Michael D. Schneider, Kristina M. Ilieva, D. O’Regan, 2015, Circulation. Cardiovascular genetics.

Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome

Kristina M. Ilieva, J. Spicer, S. Till, 2020, Cells.

Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling.

Kristina M. Ilieva, S. Tsoka, D. Dombrowicz, 2017, Cancer research.

ZBTB 17 ( MIZ 1 ) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure

Michael D. Schneider, Kristina M. Ilieva, Angharad M Roberts, 2015 .

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types

Kristina M. Ilieva, A. Tutt, S. Tsoka, 2018, Front. Immunol..

Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate

Kristina M. Ilieva, S. Pinder, J. Spicer, 2020, Allergy.

AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody

Kristina M. Ilieva, A. Tutt, J. Spicer, 2019, Allergy.

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states

Kristina M. Ilieva, S. Tsoka, J. Spicer, 2019, EBioMedicine.

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model

Kristina M. Ilieva, J. Spicer, C. Hobbs, 2019, mAbs.

An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE

Kristina M. Ilieva, S. Tsoka, D. Dombrowicz, 2018, Allergy.

Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment

Kristina M. Ilieva, F. Nestle, X. Matías-Guiu, 2019, Cell.

Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer

A. Tutt, S. Pinder, A. Grigoriadis, 2018, Clinical Cancer Research.

Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma

Kristina M. Ilieva, I. Fentiman, J. Taylor‐Papadimitriou, 2015, Oncoimmunology.

Targeting folate receptor alpha for cancer treatment

Kristina M. Ilieva, A. Tutt, A. Grigoriadis, 2016, Oncotarget.

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)

Kristina M. Ilieva, A. Tutt, J. Spicer, 2017, Oncoimmunology.

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment

Kristina M. Ilieva, K. Ilieva, S. Karagiannis, 2017, Oncoimmunology.

Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma

Kristina M. Ilieva, F. Nestle, J. Spicer, 2014, Molecular Cancer Therapeutics.

BRAF inhibitors: resistance and the promise of combination treatments for melanoma

Daniel C. Scotto, Kristina M. Ilieva, J. Spicer, 2017, Oncotarget.

Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models

Kristina M. Ilieva, T. Slidel, R. Wilkinson, 2021, Journal for ImmunoTherapy of Cancer.

IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin

Kristina M. Ilieva, F. Villanova, F. Nestle, 2016, Scientific Reports.

Binding of human BiP to the ER stress transducers IRE1 and PERK requires ATP.

Kristina M. Ilieva, K. Polizzi, K. Ilieva, 2012, Biochemical and biophysical research communications.

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields

Kristina M. Ilieva, A. Tutt, J. Spicer, 2017, Front. Immunol..

Colorectal cancer invasiveness in vitro: Predominant contribution of neonatal Nav1.5 under normoxia and hypoxia

Kristina M. Ilieva, K. Ilieva, M. Djamgoz, 2018, Journal of cellular physiology.

Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology

Kristina M. Ilieva, A. Tutt, J. Spicer, 2018, The Journal of allergy and clinical immunology.

AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor

Kristina M. Ilieva, K. Ilieva, S. Karagiannis, 2018, The Journal of allergy and clinical immunology.

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells

Kristina M. Ilieva, A. Tutt, F. Nestle, 2018, Front. Immunol..

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4

Kristina M. Ilieva, S. Tsoka, J. Downward, 2023, Nature communications.

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial

Kristina M. Ilieva, S. Canevari, U. Banerji, 2023, Nature communications.